DOX EMR

DOX EMR (official disclosure identifies DOX EMR V 5.2; specialty-specific EMR/EHR with front office, patient portal, clinical charting, billing options and ONC certification)

DOX EMR · Review dated 2026-10-13

Not publicly disclosed; request a quote. The official site advertises a free demo, but no public core subscription/license amount, currency, cadence, billing unit, plan minimum, implementation minimum, or contract term was found. The official ONC cost disclosure says certain external-service/API costs are variable and subject to change based on each vendor's annual negotiated group rate, without publishing amounts.

Billing model

Quote-based/negotiated. No first-party evidence of per-provider, per-user, per-encounter, monthly, annual, percentage-of-collections, or other core billing cadence/rate; no public minimums or free product tier. A free demo is a sales/demo offer, not a free-product price.

Fees and add-ons

Setup, migration, training, support, telehealth, payment processing and transaction fees: not publicly disclosed on the official pages reviewed. eRx: Acrendo/New Crop is embedded for e-prescribing; its cost is stated to be variable and subject to change based on an annual negotiated group rate with that vendor, with no amount or cadence. Direct messaging: EMR Direct embedded; cost likewise variable/negotiated and undisclosed. FHIR (g)(10)/API: Health Samurai-AidBox embedded; API fees apply to any user for all use, with amount variable and subject to the annual negotiated group rate; no numeric fee. Billing/RCM: official billing page describes (1) a bridge sending billing codes to applications such as Lytec, Medisoft and GE Centricity, (2) third-party billing/RCM relationships, and e-eligibility checks, but publishes no bridge, clearinghouse, RCM percentage, claim, eligibility, payment, or transaction amounts. No separate published amounts were found for eRx/EPCS, telehealth, support, implementation, data migration, training, or procurement/contract terms.

Availability and public pricing

Current commercial availability for U.S. providers is supported, but with a caveat: the live first-party site explicitly markets DOX as a specialty-specific EMR, provides a U.S. 877 phone number and free-demo/contact path, and reports 2025 Real World Testing (1/1/25–12/31/25). It is a human-health clinical product with charting, diagnoses, treatments, prescriptions/orders and billing workflows. The pages are legacy-looking and use older Meaningful Use terminology; no current customer list or explicit sales-territory statement was found. Therefore treat DOX EMR as currently offered to U.S. providers, while reconfirming operational support and contracting directly before purchase.

Qualifications

The candidate queue's identity caveat is retained: official pages provide little corporate detail and appear dated; the official LinkedIn page was listed in the queue but was not used as a pricing source. The official costs disclosure records certification date 2022-01-31 and product version V5.2, while the site reports 2025 testing; this supports continuity but does not establish a current rate card. Do not infer any amount from third-party snippets or directory/aggregator claims. All amounts are unavailable except the official statement that certain vendor/API costs are variable negotiated rates.